Kfar Saba, Israel

Gilad Goldhirsh

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Gilad Goldhirsh

Introduction

Gilad Goldhirsh is a notable inventor based in Kfar Saba, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on peptides and their applications in medical therapies.

Latest Patents

Goldhirsh holds a patent for a peptide that comprises the amino acid sequence set forth in WILVRLW (SEQ ID NO: 1). This patent describes a complex, conjugate, or chimera that includes the peptide, which can be linked with or without a linker to RING or to a molecule that recruits E3 ligase. The method for treating cancer involves administering this peptide, showcasing his commitment to advancing cancer therapies. He has 1 patent to his name.

Career Highlights

Goldhirsh is associated with the Technion Research & Development Foundation Limited, where he continues to push the boundaries of scientific research. His work is characterized by a strong focus on innovative solutions to complex medical challenges.

Collaborations

He has collaborated with esteemed colleagues such as Aaron J. Ciechanover and Yelena Kravtsova, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Gilad Goldhirsh's contributions to cancer treatment through his innovative peptide research exemplify the vital role of inventors in advancing medical science. His work not only highlights his individual achievements but also underscores the importance of collaboration in the field of research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…